BLADE Entertainment CO.,LTD.

A044480

KR7044480002

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-20 pm EDT			5-day change	1st Jan Change
1,397 ^KRW	-8.75%		+37.10%	+23.63%

2023	BLADE Entertainment CO.,LTD. announced that it has received KRW 1.999999596 billion in funding	CI
2023	Blade Entertainment to Raise 2 Billion Won From Shares Issuance; Shares Climb 4%	MT

BioGenetics CO.,LTD. announced that it has received KRW 20 billion in funding from Widwin Investment Co., Ltd.

November 26, 2019

On November 27, 2019, BioGenetics CO.,LTD. (KOSDAQ:A044480) closed the transaction.

Latest news about BLADE Entertainment CO.,LTD.

BLADE Entertainment CO.,LTD. announced that it has received KRW 1.999999596 billion in funding	23-07-03	CI
Blade Entertainment to Raise 2 Billion Won From Shares Issuance; Shares Climb 4%	23-06-21	MT
BLADE Entertainment CO.,LTD. announced that it expects to receive KRW 1.999999596 billion in funding	23-06-20	CI
BLADE Entertainment CO.,LTD. announced that it expects to receive KRW 10 billion in funding	23-01-05	CI
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 9.02379645 billion in funding from Blueberry NFT CO.,LTD.	21-12-23	CI
Blueberry NFT CO.,LTD. announced that it has received KRW 6 billion in funding	21-12-09	CI
Blueberry NFT CO.,LTD. announced that it expects to receive KRW 6 billion in funding	21-11-29	CI
Blueberry NFT CO.,LTD. announced that it has received KRW 5 billion in funding from Metaplex Co., Ltd.	21-11-28	CI
Blueberry NFT CO.,LTD. announced that it expects to receive KRW 5 billion in funding from Metaplex Co., Ltd.	21-11-23	CI
Blueberry NFT CO.,LTD. announced that it has received KRW 6.999999435 billion in funding from Jang San Co.,Ltd.	21-11-08	CI
Blueberry NFT CO.,LTD. announced that it expects to receive KRW 6.999999435 billion in funding from Jang San Co.,Ltd.	21-09-23	CI
Kyung Nam Pharm HealthCare Co.,Ltd. announced that it has received KRW 3.999997925 billion in funding from Blueberry NFT CO.,LTD., Kyung Nam Pharm Co.,Ltd.	21-07-19	CI
Kyung Nam Pharm HealthCare Co.,Ltd. announced that it expects to receive KRW 3.999997925 billion in funding from Blueberry NFT CO.,LTD., Kyung Nam Pharm Co.,Ltd.	21-07-11	CI
Blueberry NFT CO.,LTD. announced that it has received KRW 9.999999625 billion in funding from Jangsan Co., Ltd.	21-04-14	CI
Kyung Nam Biopharma CO.,LTD. announced that it expects to receive KRW 9.999999625 billion in funding from Jangsan Co., Ltd.	21-03-09	CI
Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 1.9999997 billion in funding from KyungNam Biopharma CO.,LTD.	20-06-30	CI
Livefinancial Co.,Ltd. acquired additional 5.8% stake in KyungNam Biopharma CO.,LTD. from Widwin Investment Co., Ltd. for KRW 4 billion.	20-06-03	CI
ESV Inc. announced that it has received KRW 4.999999932 billion in funding from KyungNam Biopharma CO.,LTD.	20-05-31	CI
KyungNam Biopharma CO.,LTD. announced that it has received KRW 1.499998005 billion in funding from Livefinancial Co.,Ltd.	20-04-02	CI
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 1.9999997 billion in funding from BioGenetics CO.,LTD.	20-03-29	CI
BioGenetics CO.,LTD. announced that it expects to receive KRW 1.499998005 billion in funding from Livefinancial Co.,Ltd.	20-03-25	CI
CODI-M Co., LTD. announced that it has received KRW 1.999999944 billion in funding from BioGenetics CO.,LTD.	20-03-17	CI
ESV Inc. announced that it expects to receive KRW 4.999999932 billion in funding	20-02-26	CI
BioGenetics CO.,LTD. announced that it has received KRW 20 billion in funding from Widwin Investment Co., Ltd.	19-11-26	CI
BioGenetics CO.,LTD. announced that it expects to receive KRW 20 billion funding from Widwin Investment Co., Ltd. and other investors	19-11-05	CI

Chart BLADE Entertainment CO.,LTD.

Duration

Period

More charts

Blade Entertainment Co Ltd, formerly Blueberry NFT Co Ltd, is a Korea-based company primarily engaged in the manufacture and sale of pharmaceutical products. The Company is engaged in the manufacture and sale of medicines such as vitamins, placentas and health foods. The Company is also engaged in the manufacture and sale of rubber products such as condoms and gloves, as well as masks such as KF-94. In addition, the Company is engaged in the development and provision of software such as non-fungible tokens (NFTs).

Sector

Pharmaceuticals

Calendar

2024-08-12 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
BLADE ENTERTAINMENT CO.,LTD.	+23.63%	44.61M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+22.35%	44.12B
OTSUKA HOLDINGS CO., LTD.	+22.22%	22.61B
SANDOZ GROUP AG	+17.81%	15.11B
CIPLA LIMITED	+15.73%	13.61B
ZYDUS LIFESCIENCES LIMITED	+57.91%	13.34B
ONO PHARMACEUTICAL CO., LTD.	-8.98%	6.94B
THE MEDICINES COMPANY	-0.05%	6.79B
ASPEN PHARMACARE HOLDINGS LIMITED	+15.65%	5.75B
STADA ARZNEIMITTEL	-8.87%	5.73B

Generic Pharmaceuticals

BLADE Entertainment CO.,LTD.

Equities

A044480

KR7044480002

Pharmaceuticals

BioGenetics CO.,LTD. announced that it has received KRW 20 billion in funding from Widwin Investment Co., Ltd.

Latest news about BLADE Entertainment CO.,LTD.

Chart BLADE Entertainment CO.,LTD.

Company Profile

Income Statement Evolution

Sector Generic Pharmaceuticals